rs7935

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001387283.1(SMARCA4):​c.1524T>C​(p.His508His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.35 in 1,613,226 control chromosomes in the GnomAD database, including 100,586 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8201 hom., cov: 32)
Exomes 𝑓: 0.35 ( 92385 hom. )

Consequence

SMARCA4
NM_001387283.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.80

Publications

42 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 19-10994932-T-C is Benign according to our data. Variant chr19-10994932-T-C is described in ClinVar as Benign. ClinVar VariationId is 126359.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.8 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.398 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.1524T>C p.His508His synonymous_variant Exon 9 of 36 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.1524T>C p.His508His synonymous_variant Exon 9 of 35 ENST00000344626.10 NP_003063.2 P51532-1A7E2E1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.1524T>C p.His508His synonymous_variant Exon 9 of 36 NM_001387283.1 ENSP00000495368.1 Q9HBD4
SMARCA4ENST00000344626.10 linkc.1524T>C p.His508His synonymous_variant Exon 9 of 35 1 NM_003072.5 ENSP00000343896.4 P51532-1
SMARCA4ENST00000643549.1 linkc.1524T>C p.His508His synonymous_variant Exon 9 of 35 ENSP00000493975.1 A0A2R8Y4P4
SMARCA4ENST00000541122.6 linkc.1524T>C p.His508His synonymous_variant Exon 10 of 35 5 ENSP00000445036.2 P51532-4
SMARCA4ENST00000643296.1 linkc.1524T>C p.His508His synonymous_variant Exon 9 of 34 ENSP00000496635.1 P51532-4
SMARCA4ENST00000644737.1 linkc.1524T>C p.His508His synonymous_variant Exon 9 of 34 ENSP00000495548.1 P51532-4
SMARCA4ENST00000589677.5 linkc.1524T>C p.His508His synonymous_variant Exon 10 of 35 5 ENSP00000464778.1 P51532-3
SMARCA4ENST00000643995.1 linkc.936T>C p.His312His synonymous_variant Exon 6 of 32 ENSP00000496004.1 A0A2R8YGG3
SMARCA4ENST00000644963.1 linkc.168T>C p.His56His synonymous_variant Exon 2 of 28 ENSP00000495599.1 A0A2R8YG32
SMARCA4ENST00000644065.1 linkc.252T>C p.His84His synonymous_variant Exon 2 of 27 ENSP00000493615.1 A0A2R8Y440
SMARCA4ENST00000642350.1 linkc.12T>C p.His4His synonymous_variant Exon 1 of 27 ENSP00000495355.1 A0A2R8Y6N0

Frequencies

GnomAD3 genomes
AF:
0.325
AC:
49334
AN:
151958
Hom.:
8181
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.303
Gnomad AMI
AF:
0.320
Gnomad AMR
AF:
0.239
Gnomad ASJ
AF:
0.350
Gnomad EAS
AF:
0.243
Gnomad SAS
AF:
0.413
Gnomad FIN
AF:
0.368
Gnomad MID
AF:
0.364
Gnomad NFE
AF:
0.349
Gnomad OTH
AF:
0.320
GnomAD2 exomes
AF:
0.328
AC:
82139
AN:
250764
AF XY:
0.339
show subpopulations
Gnomad AFR exome
AF:
0.302
Gnomad AMR exome
AF:
0.190
Gnomad ASJ exome
AF:
0.340
Gnomad EAS exome
AF:
0.235
Gnomad FIN exome
AF:
0.359
Gnomad NFE exome
AF:
0.351
Gnomad OTH exome
AF:
0.346
GnomAD4 exome
AF:
0.352
AC:
514614
AN:
1461150
Hom.:
92385
Cov.:
37
AF XY:
0.355
AC XY:
258355
AN XY:
726880
show subpopulations
African (AFR)
AF:
0.305
AC:
10196
AN:
33466
American (AMR)
AF:
0.197
AC:
8799
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.344
AC:
8988
AN:
26134
East Asian (EAS)
AF:
0.226
AC:
8980
AN:
39696
South Asian (SAS)
AF:
0.433
AC:
37300
AN:
86230
European-Finnish (FIN)
AF:
0.361
AC:
19260
AN:
53388
Middle Eastern (MID)
AF:
0.386
AC:
2226
AN:
5768
European-Non Finnish (NFE)
AF:
0.358
AC:
398035
AN:
1111428
Other (OTH)
AF:
0.345
AC:
20830
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
18653
37306
55960
74613
93266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12722
25444
38166
50888
63610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.325
AC:
49391
AN:
152076
Hom.:
8201
Cov.:
32
AF XY:
0.326
AC XY:
24220
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.304
AC:
12612
AN:
41482
American (AMR)
AF:
0.238
AC:
3639
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.350
AC:
1216
AN:
3472
East Asian (EAS)
AF:
0.244
AC:
1254
AN:
5148
South Asian (SAS)
AF:
0.413
AC:
1990
AN:
4822
European-Finnish (FIN)
AF:
0.368
AC:
3895
AN:
10582
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.349
AC:
23708
AN:
67988
Other (OTH)
AF:
0.321
AC:
677
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1749
3497
5246
6994
8743
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
510
1020
1530
2040
2550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.340
Hom.:
40294
Bravo
AF:
0.312
Asia WGS
AF:
0.333
AC:
1158
AN:
3478
EpiCase
AF:
0.362
EpiControl
AF:
0.353

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 30, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Intellectual disability, autosomal dominant 16 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Rhabdoid tumor predisposition syndrome 2 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Coffin-Siris syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Hereditary cancer-predisposing syndrome Benign:1
May 19, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
0.065
DANN
Benign
0.39
PhyloP100
-1.8
PromoterAI
0.043
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7935; hg19: chr19-11105608; COSMIC: COSV60787320; COSMIC: COSV60787320; API